Bioxodes is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of therapeutics for patients with thrombo-inflammatory diseases. We leverage our deep understanding of the thrombotic and inflammatory processes to design novel product candidates with an aim to address unmet medical needs.
Company Details
- Employees
- 13
- Founded
- -
- Address
- Rue Santos-Dumont, 1, Brussels South Charleroi Biopark,belgium
- Industry
- Biotechnology
- Website
- http://www.bioxodes.com
- Keywords
- Hemorrhagic stroke, Intracerebral hemorrhage, Antithrombotic, Coagulation Factor XI, Coagulation Factor XII, Thrombosis, Neuroinflammation.
- HQ
- Gosselies, Région Wallonne
Bioxodes Questions
Bioxodes's website is http://www.bioxodes.com
Bioxodes's LinkedIn profile is https://be.linkedin.com/company/bioxodes
Bioxodes has
13 employees.
View email and phone details for 13
employees at Bioxodes.
Bioxodes's industry is
Biotechnology
Bioxodes's top competitors are
Exo Biologics,
Santero Therapeutics,
Amyl Therapeutics,
Livedrop Bio,
Abscint,
Neuroclues,
Novadip Biosciences S.a.,
Esobiotec,
Atbtherapeutics,
Pdc*line Pharma.
Bioxodes's categories are Biotechnology
Bioxodes's founding year is 2013
